Overview
Lympha Press designs and distributes dynamic compression therapy devices used at home to treat lymphedema, lipedema, chronic wounds, and venous disease. The products are built around programmable, adjustable cuffs that deliver sequential or user-selected compression cycles to stimulate lymphatic and venous flow, following principles of manual lymph drainage. The devices range from consumer home units to advanced systems, offering multiple therapy modes and flexible settings to fit different patient needs. Compared to others, Lympha Press has a long history (40+ years) and a broad international footprint (worldwide distribution in 37 countries), backed by clinical evidence from over 20 peer-reviewed publications, and a distribution model in the United States via exclusive durable medical equipment partners. Its goal is to improve patients’ quality of life by providing reliable, evidence-supported home treatment with strong support, reimbursement and service networks.
Work here?Claim your company
Simplify's take
What believers are saying
- August 2026 Top Workplaces win supports recruiting in a specialized medical-device niche.
- LymphaPod broadens addressable patients and opens more bariatric and complex-contour use cases.
- NIH-backed GLP-1 lymphatic research could expand future indications and clinician attention.
What critics are saying
- Medicare prior authorization since April 2026 slows patient starts and burdens sales cycles.
- GLP-1 therapies could reduce demand if clinicians adopt drug-based lymphatic treatment.
- Mego Afek owns the business; dependence on one manufacturer creates a single-point failure risk.
What makes Lympha Press unique
- Patented overlapping chambers deliver smoother sequential compression than standard pneumatic devices.
- LymphaPod launched August 2026 for larger patients and complex body contours.
- Company-led research webinars with physicians strengthen clinical credibility around lymphedema and lipedema.
Help us improve and share your feedback! Did you find this helpful?